MARKET INDEX
KOSPI2,609.91▼ 0.76%
KOSDAQ820.64▼ 0.95%
S&P 5005,864.67▲ 0.86%
NASDAQ18,373.61▲ 0.96%
USD/KRW1,354.50▲ 3.20 (+0.24%)
WTI Crude$70.67▼ 1.25%
BTC/USD$68,450▲ 1.45%
KOSPI2,609.91▼ 0.76%
KOSDAQ820.64▼ 0.95%
S&P 5005,864.67▲ 0.86%
NASDAQ18,373.61▲ 0.96%
USD/KRW1,354.50▲ 3.20 (+0.24%)
WTI Crude$70.67▼ 1.25%
BTC/USD$68,450▲ 1.45%
헤더 좌
헤더 우
BREAKING
MARKET Times 공식 배너

The Significance of 1.88 Million: How Small, Cute Characters Are Moving the Box Office

Japan's animated film "Chiikawa: The Secret of the Mermaid Island" has drawn nearly 1.88 million cumulative viewers, sparking discussions about fandom-driven consumption and the commercial potential of intellectual property beyond mere box office success.

The Significance of 1.88 Million: How Small, Cute Characters Are Moving the Box Office
MTIMES Archive / Photo

No. 1 at the box office for seven consecutive days… Fandom attachment converts to paid viewership.

Attention shifts toward IP business potential beyond theatrical success.

Small, cute characters have taken center stage at the box office. The Japanese animated film "Chiikawa: The Secret of the Mermaid Island" continues its strong box office run, approaching a cumulative total of 1.88 million moviegoers. Given that affection for the characters is directly translating into theater attendance, this performance serves as a notable case study illustrating the shift in fandom consumption alongside a film's commercial success. 

According to data compiled by the Korean Film Council’s integrated ticket computer network on the 21st, "Chiikawa: The Secret of the Mermaid Island" drew 22,474 viewers the previous day to claim the top spot at the daily box office. Its cumulative audience has reached 1,875,607 since its release on the 30th of last month. 

On the same day, "The Assassin(s)" ranked second with 16,150 viewers, while "Tazza: The Song of Beelzebub" came in third with 11,818. As of 9:00 p.m. on the 21st, "Chiikawa" also led advance ticket sales with 61,636 tickets, commanding a 26.3% reservation rate. 

Source: KOFIC Integrated Ticket Computer Network

Going to See a 'Favorite Subject', Not Just a Story

The "Chiikawa" theatrical version follows Chiikawa and friends as they journey to an uncharted island tempted by a hundred-fold reward, uncovering hidden secrets along the way. According to the Korean Film Council’s webzine data for the first week of October, opening-week viewership stood at approximately 710,000, with sales reaching roughly 7.3 billion won. It ranked second at the box office that week, trailing "The Assassin(s)". 

What stands out is that the audience secured in the opening week has sustained itself post-release. Rather than fading after initial interest, the film surpassed 1.87 million cumulative viewers as of the 20th, reclaiming the top spot in daily box office earnings.

One perspective on this box office run prompts a fundamental question: what exactly are audiences paying for? Beyond the plot and artistic quality of the film, the experience of meeting already-beloved characters on the big screen can be a primary motive for attendance. In essence, "who you are going to see" is becoming just as crucial as "what the story is about."

This suggests that fandom interest in characters is successfully channeling into theater attendance. However, publicly available box office figures alone cannot verify the exact proportion of fandom-driven audiences or the scale of repeat viewings. The fact that popularity has translated into attendance, and the extent to which this connection occurs across different demographic segments, remain distinct matters.

Box Office Potential vs. Profitability: A Separate Calculation

From the perspective of the content industry, this case poses a critical question: to what extent can character brand awareness be converted into paid consumption?

While the film delivers new storylines to existing fans, it simultaneously acts as an entry point into the worldview for audiences encountering the characters for the first time. When these dual roles function effectively, a theatrical release transcends an individual work to become a vehicle for expanding intellectual property (IP) touchpoints. This is precisely why the success of "Chiikawa" warrants examination from a character merchandising and business standpoint.

That said, rising audience numbers should not be directly equated with an increase in corporate earnings. The approximately 7.3 billion won in opening-week sales compiled by the Korean Film Council’s webzine represents theatrical ticket revenue metrics, not the gross revenue or operating profit captured by specific corporations. 

Assessing commercial viability requires a comprehensive review of domestic copyright and distribution contracts, cost burdens, and profit-sharing terms. Publicly disclosed box office data alone is insufficient to calculate these specific conditions or a company's contribution to earnings. A crucial intermediary step—the contractual structure—still lies between content popularity and investment-grade profitability.

The Next Challenge for 'Cuteness': Sustainability

Chiikawa’s current performance demonstrates that attachment to characters can exert purchasing power even within the paid consumption space of movie theaters. At the same time, future audience trends are needed to determine long-term box office viability. A cumulative count of 1.87 million and a single day at the top of the box office do not guarantee final commercial scale. 

The challenge moving forward is sustaining that interest. The franchise must deliver experiences that meet expectations for existing fans while sparking curiosity in new audiences for the next installment. When a single viewing evolves into a longer-term relationship with the characters, the underlying strength of the IP grows accordingly.

The scorecard generated by these small, cute characters is by no means trivial. The question "Chiikawa" has posed to the film industry is clear: how can the market expand an experience where people are willing to pay again to encounter the subjects they already love?

MARKET Times

MTIMES Global Editorial Statement

This analysis is provided for international business intelligence and informational purposes only. It does not constitute investment advice or a solicitation to buy or sell securities. For inquiries regarding licensing or syndication, please contact [email protected].

← More in CultureBack to Top ↑

Related Market & Corporate Intelligence

Anthropic Expands AI Business into Drug Discovery, from Antibody Optimization to Clinical SupportAnthropic Expands AI Business into Drug Discovery, from Antibody Optimization to Clinical Support700선 위기 KOSDAQ…왜 상승세를 지키지 못했나700선 위기 KOSDAQ…왜 상승세를 지키지 못했나South Korean Battery Makers Pivot to LFP and ESS Amid Evolving DemandSouth Korean Battery Makers Pivot to LFP and ESS Amid Evolving DemandWall Street Sells Off Big Tech Despite Solid Earnings: The Growing Skepticism Over AI ROIWall Street Sells Off Big Tech Despite Solid Earnings: The Growing Skepticism Over AI ROI
HomeTOP10AlmatenPicksCorpAlgiten